/
© 2026 RiffOn. All rights reserved.

Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

  1. Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders
  2. 290: Batch-to-Batch Variability Is a Design Failure, Not the Norm with Sandra Núñez - Part 2
290: Batch-to-Batch Variability Is a Design Failure, Not the Norm with Sandra Núñez - Part 2

290: Batch-to-Batch Variability Is a Design Failure, Not the Norm with Sandra Núñez - Part 2

Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders · Sep 24, 2026

A biotech CEO on using a virtual plant model with CDMOs for agility, navigating tech transfers, and why batch variability is a design failure.

Frame Batch-to-Batch Variability as a Design Failure, Not an Inevitable Norm

Instead of accepting inconsistent results, proactively address the root causes. Variability is a problem that can be solved through better raw material selection, improved process design, or increased lab automation, leading to more reproducible and reliable outcomes.

290: Batch-to-Batch Variability Is a Design Failure, Not the Norm with Sandra Núñez - Part 2 thumbnail

290: Batch-to-Batch Variability Is a Design Failure, Not the Norm with Sandra Núñez - Part 2

Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders·2 months ago

Tech Transfer to CDMOs Fails on Human Factors, Not Technical Glitches

The success of outsourcing bioprocesses often hinges on managing interpersonal dynamics and team collaboration, which are frequently underestimated compared to technical challenges. The human element, including politics between companies, is a major pitfall where tech transfer projects struggle.

290: Batch-to-Batch Variability Is a Design Failure, Not the Norm with Sandra Núñez - Part 2 thumbnail

290: Batch-to-Batch Variability Is a Design Failure, Not the Norm with Sandra Núñez - Part 2

Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders·2 months ago

Embed Basic GMP Principles Early for a Natural Transition to Regulated Manufacturing

Instead of a jarring switch, gradually integrate GMP-like practices into daily operations, such as structured documentation and a quality-focused culture. This proactive approach smooths the eventual transition into a regulated framework without 'overkilling it' with excessive early investment.

290: Batch-to-Batch Variability Is a Design Failure, Not the Norm with Sandra Núñez - Part 2 thumbnail

290: Batch-to-Batch Variability Is a Design Failure, Not the Norm with Sandra Núñez - Part 2

Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders·2 months ago

Redevelop Non-Scalable Academic Processes Early, Even If It Risks Short-Term Quality

Lab-scale processes often contain methods, like certain purifications, that are not commercially scalable. It is critical to identify and redevelop these elements early to avoid hitting a manufacturing wall, even if it introduces temporary changes to the product profile.

290: Batch-to-Batch Variability Is a Design Failure, Not the Norm with Sandra Núñez - Part 2 thumbnail

290: Batch-to-Batch Variability Is a Design Failure, Not the Norm with Sandra Núñez - Part 2

Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders·2 months ago